Why do regenal injection products stand out from the others?
Because they are produced by a long-term cross-linking procedure (gentle cross-linking) at low temperatures.
Slow mixing allows the BDDE cross-linking agent to spread better and more evenly.
It is also worth noting that the amount of BDDE used in these products is 30 less than that of competitors.
In addition, the different Hyaluronic Acid molecule weights obtained allow the material’s waxing properties to be better adjusted according to the prescribed usage and location.
Therefore, regenyal products are extremely homogeneous and ticsotropic. These are particle-free single-phase gels, consisting of a single liquid gel-thick phase, penetrating tissues and spreading perfectly, and lastbut ingressingly more permanently. This innovative manufacturing method is protected by an international patent.
International Patent
Regarding the invention of a special single phase gel obtained through a long special period of cross-linking procedure at low temperatures. Slow mixing allows the cross-linking agent (BDDE) to spread better and more evenly.
The result is a homogeneous gel that spreads to tissues and integrates and produces better results than common particulate gels.
Certifications
Regenyal Laboratories have the following certifications:
ISO 9001 – Quality Management Systems – to manage the company’s processes in the best way, to improve efficiency and efficiency in production and services, to ensure and increase customer satisfaction
ISO 13485 – Quality Management Systems for medical devices
ISO 14001 – The International Standard Company for Environmental Management complies with the European GMP (Good Manufacturing Practices) rules.
CE CERTIFICATIONS are issued by The Approved Body (Istituto Superiore di Sanità) number 0373.